bioAffinity Technologies, Inc. Pre-Tax Income
bioAffinity Technologies, Inc. (BIAF) reported Pre-Tax Income of -$3.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-07
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$3.37M.
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$3.63M.
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$3.13M.
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$5.05M.
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$14.87M.
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$9.03M.
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$7.92M.
- bioAffinity Technologies, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$8.15M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.37M 10-Q · filed 2026-08-07 | -$7.00M 10-Q · filed 2026-08-07 | -$10.13M derived: sum of 3 quarters · filed 2026-08-07 | -$15.18M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$3.63M 10-Q · filed 2026-05-11 | -$6.76M derived: sum of 2 quarters · filed 2026-05-11 | -$11.81M derived: sum of 3 quarters · filed 2026-05-11 | -$15.84M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$8.18M derived: sum of 2 quarters · filed 2026-03-16 | -$12.21M derived: sum of 3 quarters · filed 2026-08-07 | -$14.87M 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$5.05M 10-Q · filed 2025-11-14 | -$9.08M derived: sum of 2 quarters · filed 2026-08-07 | -$11.73M 10-Q · filed 2025-11-14 | -$14.70M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$4.03M 10-Q · filed 2026-08-07 | -$6.68M 10-Q · filed 2026-08-07 | -$9.65M derived: sum of 3 quarters · filed 2026-08-07 | -$11.65M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | -$2.65M 10-Q · filed 2026-05-11 | -$5.62M derived: sum of 2 quarters · filed 2026-05-11 | -$7.62M derived: sum of 3 quarters · filed 2026-05-11 | -$9.72M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$4.97M derived: sum of 2 quarters · filed 2026-03-16 | -$7.07M derived: sum of 3 quarters · filed 2026-03-16 | -$9.03M 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$2.00M 10-Q · filed 2025-11-14 | -$4.10M derived: sum of 2 quarters · filed 2025-11-14 | -$6.06M 10-Q · filed 2025-11-14 | -$8.43M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$2.10M 10-Q · filed 2025-08-14 | -$4.06M 10-Q · filed 2025-08-14 | -$6.43M derived: sum of 3 quarters · filed 2025-08-14 | -$8.72M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$1.96M 10-Q · filed 2025-05-15 | -$4.33M derived: sum of 2 quarters · filed 2025-05-15 | -$6.62M derived: sum of 3 quarters · filed 2025-05-15 | -$8.35M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$4.66M derived: sum of 2 quarters · filed 2025-03-31 | -$6.40M derived: sum of 3 quarters · filed 2025-03-31 | -$7.92M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$2.29M 10-Q · filed 2024-11-14 | -$4.02M derived: sum of 2 quarters · filed 2024-11-14 | -$5.55M 10-Q · filed 2024-11-14 | -$7.22M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$1.74M 10-Q · filed 2024-08-14 | -$3.26M 10-Q · filed 2024-08-14 | -$4.93M derived: sum of 3 quarters · filed 2024-08-14 | -$9.85M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$1.52M 10-Q · filed 2024-05-15 | -$3.20M derived: sum of 2 quarters · filed 2024-05-15 | -$8.11M derived: sum of 3 quarters · filed 2024-05-15 | -$8.20M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$6.59M derived: sum of 2 quarters · filed 2024-04-01 | -$6.68M derived: sum of 3 quarters · filed 2024-04-01 | -$8.15M 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$4.92M 10-Q · filed 2023-11-14 | -$5.01M derived: sum of 2 quarters · filed 2023-11-14 | -$6.48M 10-Q · filed 2023-11-14 | -$6.48M 10-Q · filed 2022-11-14 | -$12.05M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$88.05K 10-Q · filed 2023-08-14 | -$1.56M 10-Q · filed 2023-08-14 | -$7.13M derived: sum of 3 quarters · filed 2023-08-14 | -$8.65M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$1.47M 10-Q · filed 2023-05-15 | -$7.05M derived: sum of 2 quarters · filed 2023-05-15 | -$8.56M derived: sum of 3 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$7.09M derived: sum of 2 quarters · filed 2023-03-31 | -$6.32M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$1.51M 10-Q · filed 2022-11-14 | -$747.58K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |